Nicholas Withers

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

The Natural History of Respiratory Symptoms in a Cohort of Adolescents

Nicholas Withers, Lorraine A. Low, Stephen T. Holgate et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 120 citations

Public Health, Child Health, Pediatrics +11

Iron Deficiency in Cystic Fibrosis

David W. Reid, Nicholas Withers, Libby Francis et al. · CHEST Journal · 2002 · 115 citations

Medicine, Pathobiology, Iron Metabolism Disorders +9

Anxiety and Depression in Severe Chronic Obstructive Pulmonary Disease: The Effects of Pulmonary Rehabilitation

Nicholas Withers, Sharon T. Rudkin, Roger J. White · Journal of Cardiopulmonary Rehabilitation · 1999 · 112 citations

Medicine, Rehabilitation Medicine, Pulmonary Function Testing +14

Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one<i>F508del</i>allele: 144-week interim results from a 192-week open-label extension study

Cori Daines, Elizabeth Tullis, Stefano Costa et al. · European Respiratory Journal · 2023 · 88 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16